APGE
Price
$134.09
Change
-$0.21 (-0.16%)
Updated
Jul 31 closing price
Capitalization
10.14B
14 days until earnings call
Intraday BUY SELL Signals
ORKA
Price
$96.51
Change
-$1.35 (-1.38%)
Updated
Jul 31 closing price
Capitalization
5.82B
14 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

APGE vs ORKA

APGE vs ORKA Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
APGE vs. ORKA commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Hold and ORKA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 03, 2026
Stock price -- (APGE: $134.09 vs. ORKA: $96.51)
Brand notoriety: APGE and ORKA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 35% vs. ORKA: 37%
Market capitalization -- APGE: $10.14B vs. ORKA: $5.82B
APGE [@Biotechnology] is valued at $10.14B. ORKA’s [@Biotechnology] market capitalization is $5.82B. The market cap for tickers in the [@Biotechnology] industry ranges from $121.09B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileORKA’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • ORKA’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than ORKA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 3 TA indicator(s) are bullish while ORKA’s TA Score has 2 bullish TA indicator(s).

  • APGE’s TA Score: 3 bullish, 3 bearish.
  • ORKA’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, APGE is a better buy in the short-term than ORKA.

Price Growth

APGE (@Biotechnology) experienced а -0.14% price change this week, while ORKA (@Biotechnology) price change was +4.72% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.22%. For the same industry, the average monthly price growth was -8.12%, and the average quarterly price growth was +2790.29%.

Reported Earning Dates

APGE is expected to report earnings on Aug 17, 2026.

ORKA is expected to report earnings on Aug 17, 2026.

Industries' Descriptions

@Biotechnology (-1.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($10.1B) has a higher market cap than ORKA($5.82B). ORKA YTD gains are higher at: 218.410 vs. APGE (77.650). ORKA has higher annual earnings (EBITDA): -116.67M vs. APGE (-303.65M). APGE has more cash in the bank: 1.06B vs. ORKA (389M). ORKA has less debt than APGE: ORKA (1.81M) vs APGE (8.05M). APGE (0) and ORKA (0) have equivalent revenues.
APGEORKAAPGE / ORKA
Capitalization10.1B5.82B174%
EBITDA-303.65M-116.67M260%
Gain YTD77.650218.41036%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.06B389M272%
Total Debt8.05M1.81M445%
FUNDAMENTALS RATINGS
ORKA: Fundamental Ratings
ORKA
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
56
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGEORKA
RSI
ODDS (%)
N/A
Bearish Trend 4 days ago
83%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
82%
Bearish Trend 4 days ago
73%
Momentum
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
64%
MACD
ODDS (%)
Bearish Trend 4 days ago
65%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
76%
Bullish Trend 4 days ago
71%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
74%
Advances
ODDS (%)
Bullish Trend 5 days ago
85%
N/A
Declines
ODDS (%)
Bearish Trend 18 days ago
67%
Bearish Trend 12 days ago
75%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
APGE
Daily Signal:
Gain/Loss:
ORKA
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XLO9.110.03
+0.33%
Xilio Therapeutics Inc.
HIMX12.54N/A
N/A
Himax Technologies
KBONU10.29N/A
N/A
Karbon Capital Partners Corp
MUSA607.76-8.34
-1.35%
Murphy USA
EPRX6.40-0.15
-2.29%
Eupraxia Pharmaceuticals

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with DFTX. These tickers have moved in lockstep 50% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then DFTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
-0.16%
DFTX - APGE
50%
Loosely correlated
-2.18%
ORKA - APGE
49%
Loosely correlated
-1.38%
SYRE - APGE
49%
Loosely correlated
-3.12%
RCUS - APGE
41%
Loosely correlated
-0.21%
IMVT - APGE
40%
Loosely correlated
-2.18%
More